| Arthur Albert Ruediger, DO | |
|
59 Page Hill Rd, Berlin, NH 03570-3531 | |
| (603) 752-2200 | |
| Not Available |
| Full Name | Arthur Albert Ruediger |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 59 Page Hill Rd, Berlin, New Hampshire |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528110194 | NPI | - | NPPES |
| H27260 | Other | NH | HARVARD PILGRIM HEALTH CA |
| 7111690 | Other | NH | CIGNA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 11037 (New Hampshire) | Primary |
| 207Q00000X | Family Medicine | 11037 (New Hampshire) | Secondary |
| Entity Name | Upper Connecticut Valley Hospital Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861489437 PECOS PAC ID: 3870485923 Enrollment ID: O20040325000768 |
News Archive
Rewarding learning today can improve learning tomorrow; this is one of the conclusions reached by researchers from the Cognition and Brain Plasticity research group of the Institute of Biomedical Research of Bellvitge and the University of Barcelona in their last work on the impact of emotions on the way we remember things.
Janssen Research & Development, LLC announced data from the Phase 3 multicenter study SAR3007, which demonstrated a significant improvement in progression-free survival with trabectedin (YONDELIS®) compared to dacarbazine in patients with advanced liposarcoma (LPS) or leiomyosarcoma (LMS) previously treated with an anthracycline and at least one additional chemotherapy regimen.
The case of a patient who experienced two facial palsies – one after the first and another after the second dose of the Pfizer-BioNTech COVID-19 vaccine – strongly suggests that Bell's palsy (facial nerve palsy of unknown cause) is linked to the Pfizer-BioNTech vaccine, doctors write in the journal BMJ Case Reports.
Today Astellas Pharma US, Inc. announced results of a Phase IV study showing Lexiscan(regadenoson) Injection was comparable to placebo in causing a >15% decrease in forced expiratory volume in one second (FEV1) in subjects with asthma or chronic obstructive pulmonary disease (COPD) who are likely candidates for myocardial perfusion imaging (MPI) studies.
› Verified 7 days ago
| Entity Name | Androscoggin Valley Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386680593 PECOS PAC ID: 2365350725 Enrollment ID: O20040402000121 |
News Archive
Rewarding learning today can improve learning tomorrow; this is one of the conclusions reached by researchers from the Cognition and Brain Plasticity research group of the Institute of Biomedical Research of Bellvitge and the University of Barcelona in their last work on the impact of emotions on the way we remember things.
Janssen Research & Development, LLC announced data from the Phase 3 multicenter study SAR3007, which demonstrated a significant improvement in progression-free survival with trabectedin (YONDELIS®) compared to dacarbazine in patients with advanced liposarcoma (LPS) or leiomyosarcoma (LMS) previously treated with an anthracycline and at least one additional chemotherapy regimen.
The case of a patient who experienced two facial palsies – one after the first and another after the second dose of the Pfizer-BioNTech COVID-19 vaccine – strongly suggests that Bell's palsy (facial nerve palsy of unknown cause) is linked to the Pfizer-BioNTech vaccine, doctors write in the journal BMJ Case Reports.
Today Astellas Pharma US, Inc. announced results of a Phase IV study showing Lexiscan(regadenoson) Injection was comparable to placebo in causing a >15% decrease in forced expiratory volume in one second (FEV1) in subjects with asthma or chronic obstructive pulmonary disease (COPD) who are likely candidates for myocardial perfusion imaging (MPI) studies.
› Verified 7 days ago
| Entity Name | Weeks Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508819566 PECOS PAC ID: 2769461284 Enrollment ID: O20040719000284 |
News Archive
Rewarding learning today can improve learning tomorrow; this is one of the conclusions reached by researchers from the Cognition and Brain Plasticity research group of the Institute of Biomedical Research of Bellvitge and the University of Barcelona in their last work on the impact of emotions on the way we remember things.
Janssen Research & Development, LLC announced data from the Phase 3 multicenter study SAR3007, which demonstrated a significant improvement in progression-free survival with trabectedin (YONDELIS®) compared to dacarbazine in patients with advanced liposarcoma (LPS) or leiomyosarcoma (LMS) previously treated with an anthracycline and at least one additional chemotherapy regimen.
The case of a patient who experienced two facial palsies – one after the first and another after the second dose of the Pfizer-BioNTech COVID-19 vaccine – strongly suggests that Bell's palsy (facial nerve palsy of unknown cause) is linked to the Pfizer-BioNTech vaccine, doctors write in the journal BMJ Case Reports.
Today Astellas Pharma US, Inc. announced results of a Phase IV study showing Lexiscan(regadenoson) Injection was comparable to placebo in causing a >15% decrease in forced expiratory volume in one second (FEV1) in subjects with asthma or chronic obstructive pulmonary disease (COPD) who are likely candidates for myocardial perfusion imaging (MPI) studies.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Arthur Albert Ruediger, DO 59 Page Hill Rd, Berlin, NH 03570-3531 Ph: (603) 752-2200 | Arthur Albert Ruediger, DO 59 Page Hill Rd, Berlin, NH 03570-3531 Ph: (603) 752-2200 |
News Archive
Rewarding learning today can improve learning tomorrow; this is one of the conclusions reached by researchers from the Cognition and Brain Plasticity research group of the Institute of Biomedical Research of Bellvitge and the University of Barcelona in their last work on the impact of emotions on the way we remember things.
Janssen Research & Development, LLC announced data from the Phase 3 multicenter study SAR3007, which demonstrated a significant improvement in progression-free survival with trabectedin (YONDELIS®) compared to dacarbazine in patients with advanced liposarcoma (LPS) or leiomyosarcoma (LMS) previously treated with an anthracycline and at least one additional chemotherapy regimen.
The case of a patient who experienced two facial palsies – one after the first and another after the second dose of the Pfizer-BioNTech COVID-19 vaccine – strongly suggests that Bell's palsy (facial nerve palsy of unknown cause) is linked to the Pfizer-BioNTech vaccine, doctors write in the journal BMJ Case Reports.
Today Astellas Pharma US, Inc. announced results of a Phase IV study showing Lexiscan(regadenoson) Injection was comparable to placebo in causing a >15% decrease in forced expiratory volume in one second (FEV1) in subjects with asthma or chronic obstructive pulmonary disease (COPD) who are likely candidates for myocardial perfusion imaging (MPI) studies.
› Verified 7 days ago
Robert J Wise, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 59 Page Hill Rd, Berlin, NH 03570 Phone: 603-752-2200 | |
Elisabeth Moore, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 59 Page Hill Rd, Berlin, NH 03570 Phone: 603-752-2200 Fax: 603-752-1836 | |
Faith M. Pinkerton, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 59 Page Hill Rd, Berlin, NH 03570 Phone: 603-752-2200 Fax: 603-752-1836 | |
Peter Joseph Schroer, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 59 Page Hill Road, Berlin, NH 03570 Phone: 603-752-2200 Fax: 603-326-5832 |